{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-09-09", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "667489ad-f604-4204-8e96-1d099ff046fa", "code": "P21728", "type": "PRIMARY", "url": "http://www.uniprot.org/uniprot/P21728?sort=score", "code_system": "UNIPROT", "references": [ "d864c48c-18e0-4f45-aea9-2dd2eefdf2fa" ] }, { "uuid": "3b977fc3-fff5-4e44-aca3-55e17c144473", "code": "P21728", "type": "PRIMARY", "url": "https://pharos.nih.gov/idg/search?q=P21728", "code_system": "PHAROS", "references": [ "d864c48c-18e0-4f45-aea9-2dd2eefdf2fa" ] }, { "uuid": "96ff3a68-4365-4b10-b490-83aca72635dc", "code": "54202V7DRJ", "type": "PRIMARY", "code_system": "FDA UNII" } ], "substance_class": "protein", "references": [ { "uuid": "d6c67b1d-3a82-4f10-9c22-38928529262c", "citation": "Halldin, Christer, et al. \"Carbon-11-NNC 112: A Radioligand for PET Examination of Striatal and Neocortical D~ 1-Dopamine Receptors.\" Journal of Nuclear Medicine 39 (1998): 2061-2068.", "url": "http://jnm.snmjournals.org/content/39/12/2061.full.pdf", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "5ac32da5-262c-4b54-95c3-d89c79affbc5", "citation": "Halldin, Christer, et al. \"Carbon-11-NNC 112: A Radioligand for PET Examination of Striatal and Neocortical D~ 1-Dopamine Receptors.\" Journal of Nuclear Medicine 39 (1998): 2061-2068.", "url": "http://jnm.snmjournals.org/content/39/12/2061.full.pdf", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c8907c77-e88d-484e-a577-1e3d48075269", "citation": "Malo, Marcus, et al. \"Investigation of D1 receptor–agonist interactions and D1/D2 agonist selectivity using a combination of pharmacophore and receptor homology modeling.\" ChemMedChem 7.3 (2012): 483-494.", "url": "https://onlinelibrary.wiley.com/doi/full/10.1002/cmdc.201100546", "doc_type": "JA", "public_domain": true, "tags": [ "POT" ] }, { "uuid": "fb416556-afdd-4845-a62a-09340a9330b3", "citation": "Halldin, Christer, et al. \"Carbon-11-NNC 112: A Radioligand for PET Examination of Striatal and Neocortical D~ 1-Dopamine Receptors.\" Journal of Nuclear Medicine 39 (1998): 2061-2068.", "url": "http://jnm.snmjournals.org/content/39/12/2061.full.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "9ef76daf-9f78-46a4-b1d3-db4a564d11ad", "citation": "Front. Pharmacol., 31 March 2016, Declercq, LD, et.al.", "url": "https://www.frontiersin.org/articles/10.3389/fphar.2016.00088/full", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "ed729a66-3b6b-444b-be64-d192355664d6", "citation": "Front. Pharmacol., 31 March 2016, Declercq, LD, et.al.", "url": "https://www.frontiersin.org/articles/10.3389/fphar.2016.00088/full", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "49d13775-f51c-4667-9964-47ca190e2048", "citation": "http://www.uniprot.org/uniprot/P21728", "url": "http://www.uniprot.org/uniprot/P21728", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "38642b90-c9a0-4bd2-9ee3-033947720c9b", "citation": "UNIPROT", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "1b2a8d29-1a45-4b61-93c8-1bff00944506", "citation": "http://www.uniprot.org/uniprot/P21728?sort=score", "url": "http://www.uniprot.org/uniprot/P21728?sort=score", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d864c48c-18e0-4f45-aea9-2dd2eefdf2fa", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493393425000, "tags": [ "NOMEN" ] }, { "uuid": "5a0c19b4-8863-49b6-9865-b7d3b624b6aa", "citation": "SRS import [54202V7DRJ]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=54202V7DRJ", "doc_type": "SRS", "public_domain": true, "document_date": 1493393425000, "tags": [ "NOMEN" ] }, { "uuid": "bb56a263-e952-4ae8-ac7f-a4655371a2d5", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/209500Orig1s000MultidisciplineR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2036dd3b-f2d8-4d5c-970d-f467da0c9354", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/209500Orig1s000MultidisciplineR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "ddc4feb5-2275-4cb9-9d1b-90e9e533b48d", "citation": "Bello, Fabio Del, et al. \"Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease.\" Biomolecules 9.4 (2019): 142.", "url": "https://www.mdpi.com/2218-273X/9/4/142/htm", "doc_type": "JA", "public_domain": true }, { "uuid": "f1d71db4-5608-4465-9a04-ffcfba5c9195", "citation": "Slifstein, Mark, et al. \"Characterization of in vivo pharmacokinetic properties of the dopamine D1 receptor agonist DAR-0100A in nonhuman primates using PET with [11C] NNC112 and [11C] raclopride.\" Journal of Cerebral Blood Flow & Metabolism 31.1 (2011): 293-304.", "url": "https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2010.91", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c5e25f8d-64f0-47f7-b348-b796c3750e8b", "citation": "ITI 333 ", "url": "https://adisinsight.springer.com/drugs/800059932", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "ce9fcf9d-a4bb-4c17-bbbf-08a4f01d2533", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "651db5b5-3ce8-4b94-911d-2f162d4660c8", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7cfa4c3e-1d8b-475a-8bb2-64bc56417e91", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d48c1802-c4a8-4493-86e2-c57b4d086922", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "dfbf8e0f-6b8b-45bd-a58b-97d5ee890526", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "ef218167-84ec-438c-99a5-e57303101e3e", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "393f4331-d42a-4ce1-b438-ea4372752ef5", "citation": "WIK", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7bb992fd-04e2-4e04-85db-64ec966e765a", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "93b02996-0b28-44e0-9709-0981e731b20c", "citation": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=874e50ad-5da0-4ac3-9290-79442c91399e&audience=consumer", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=874e50ad-5da0-4ac3-9290-79442c91399e&audience=consumer", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "0355e5aa-e784-46a2-90b8-7010d96af51c", "citation": "https://www.dovepress.com/experimental-serotonergic-agents-for-the-treatment-of-schizophrenia-peer-reviewed-fulltext-article-JEP", "url": "https://www.dovepress.com/experimental-serotonergic-agents-for-the-treatment-of-schizophrenia-peer-reviewed-fulltext-article-JEP", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "93c3175b-ccd5-474b-9ded-8bec0d378f0d", "citation": "Lublin, Henrik, et al. \"Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia.\" European Neuropsychopharmacology 1.4 (1991): 541-548.", "url": "https://www.sciencedirect.com/science/article/pii/0924977X9190008I", "doc_type": "JA", "public_domain": true }, { "uuid": "a9a57609-b6df-4950-8153-ba8d9b5b1043", "citation": "Halldin, Christer, et al. \"Carbon-11-NNC 112: A Radioligand for PET Examination of Striatal and Neocortical D~ 1-Dopamine Receptors.\" Journal of Nuclear Medicine 39 (1998): 2061-2068.", "url": "http://jnm.snmjournals.org/content/39/12/2061.full.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "d0961bc7-58a9-4300-8a6e-186f35622b5f", "citation": "Nichols, David E., et al. \"Lysergamides of isomeric 2, 4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N, N-diethyllysergamide (LSD).\" Journal of Medicinal Chemistry 45.19 (2002): 4344-4349.", "url": "https://pubs.acs.org/doi/pdf/10.1021/jm020153s", "doc_type": "JA", "public_domain": true }, { "uuid": "376f49f1-14f6-42ce-b731-e3cc86d57707", "citation": "Bourne, James A. \"SCH 23390: the first selective dopamine D1‐like receptor antagonist.\" CNS drug reviews 7.4 (2001): 399-414.", "url": "https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2001.tb00207.x?sid=nlm%3Apubmed", "doc_type": "JA", "public_domain": true }, { "uuid": "b5ad9580-1355-4543-8a89-aa98e76544d3", "citation": "Bourne, James A. \"SCH 23390: the first selective dopamine D1‐like receptor antagonist.\" CNS drug reviews 7.4 (2001): 399-414.", "url": "https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2001.tb00207.x?sid=nlm%3Apubmed", "doc_type": "JA", "public_domain": true }, { "uuid": "e755d664-c028-4570-a35c-8aacfff90531", "citation": "Bourne, James A. \"SCH 23390: the first selective dopamine D1‐like receptor antagonist.\" CNS drug reviews 7.4 (2001): 399-414.", "url": "https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2001.tb00207.x?sid=nlm%3Apubmed", "doc_type": "JA", "public_domain": true } ], "definition_type": "PRIMARY", "definition_level": "COMPLETE", "uuid": "84edf12e-87a3-43e0-8526-ad45513dcd09", "version": "47", "unii": "54202V7DRJ", "relationships": [ { "uuid": "58d65b21-0100-4e79-a902-054d5fd2f872", "amount": { "uuid": "d90ae13f-6ac8-4ae8-8e7c-d6cfdb0c9307" }, "type": "AGONIST->TARGET", "related_substance": { "uuid": "6daf3790-52b9-46e7-afe7-e31acc136ff1", "refuuid": "e4e1aec1-6cd5-4da8-b10b-dccd12f52f9c", "name": "A-86929", "unii": "S3ZIH99X6E", "linking_id": "S3ZIH99X6E", "ref_pname": "A-86929" } }, { "uuid": "cfb14d94-e1d9-4979-83b4-2d3d6433a972", "amount": { "uuid": "e8a50fba-4cc3-4107-a685-fc438e4646b1" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "4f2f4a79-92c8-4db3-9b72-e59c5ed0ca62", "refuuid": "a6813f76-45ad-4c49-80e7-5a414d9a4691", "name": "ACEPROMAZINE", "unii": "54EJ303F0R", "linking_id": "54EJ303F0R", "ref_pname": "ACEPROMAZINE" } }, { "uuid": "35feab0a-0bdd-415f-9199-7a5e27c26767", "amount": { "uuid": "8b48da78-f786-47d1-8746-9b733b40d942" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "4c3b3356-c62e-4ea9-b9e5-78ca0bb61c81", "refuuid": "6bdef611-e7fd-4605-a5a9-035cc8d113e9", "name": "PERPHENAZINE", "unii": "FTA7XXY4EZ", "linking_id": "FTA7XXY4EZ", "ref_pname": "PERPHENAZINE" } }, { "uuid": "ba7e64d0-87ab-46ab-9ce4-cb65d3132f41", "type": "AGONIST->TARGET", "related_substance": { "uuid": "1596dff4-a02e-41ba-adad-e5446cf7359d", "refuuid": "7bd98463-92af-4d5a-b84e-18216b16e93f", "name": "FENOLDOPAM", "unii": "INU8H2KAWG", "linking_id": "INU8H2KAWG", "ref_pname": "FENOLDOPAM" } }, { "uuid": "2b236db2-318d-4126-9ded-6998ce1527bc", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "953f9d21-2be1-4440-9bfe-e63f3e45c4bb", "refuuid": "7c7cefa1-9e09-4173-8307-526d79607b34", "name": "CHLORPROMAZINE", "unii": "U42B7VYA4P", "linking_id": "U42B7VYA4P", "ref_pname": "CHLORPROMAZINE" } }, { "uuid": "347966a1-6cb0-4ecc-a8b5-f39b3a2cb6dd", "type": "AGONIST->TARGET", "related_substance": { "uuid": "47399fc7-55a2-4bf9-8bbf-89128e6583fc", "refuuid": "81ced566-c75d-4557-8ae1-427313f497a4", "name": "LEVODOPA", "unii": "46627O600J", "linking_id": "46627O600J", "ref_pname": "LEVODOPA" } }, { "uuid": "8485d5b8-96a5-414d-94b4-e5a0cb2bad4d", "amount": { "uuid": "d870435b-74b8-46fd-b3eb-9b831520413c", "high": 78, "low": 20, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "ANTAGONIST->TARGET", "interaction_type": "BINDING", "references": [ "bb56a263-e952-4ae8-ac7f-a4655371a2d5" ], "related_substance": { "uuid": "09715bbd-fbc5-4530-a2d8-e507d367fffe", "refuuid": "7c562b37-d1d2-46e0-8737-abfa9a9a5aec", "name": "Lumateperone", "unii": "70BSQ12069", "linking_id": "70BSQ12069", "ref_pname": "Lumateperone" } }, { "uuid": "83b4b947-a194-45aa-8f2a-02547c6a1676", "amount": { "uuid": "9c7b4986-107c-49f3-9e98-16f3a6746747", "average": 0.18, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "9ef76daf-9f78-46a4-b1d3-db4a564d11ad" ], "related_substance": { "uuid": "d5631832-71a9-48ed-9d84-b414740540f6", "refuuid": "392882a1-2838-4d54-9cd7-7eb16dcde922", "name": "ODAPIPAM", "unii": "847PQF7ZN6", "linking_id": "847PQF7ZN6", "ref_pname": "ODAPIPAM" } }, { "uuid": "e6eb0172-c9f7-4130-8649-10f142e3f887", "type": "AGONIST->TARGET", "references": [ "ddc4feb5-2275-4cb9-9d1b-90e9e533b48d" ], "related_substance": { "uuid": "937685e0-d1b1-4753-a96d-92e58c6cd046", "refuuid": "64085707-ef4c-469c-918f-0e670c47b6c3", "name": "TAVAPADON", "unii": "PT4P8MJP8L", "linking_id": "PT4P8MJP8L", "ref_pname": "TAVAPADON" } }, { "uuid": "b5f03a51-7165-4df9-bc76-cd6270d6a0e8", "type": "RADIOLIGAND->TARGET", "references": [ "ed729a66-3b6b-444b-be64-d192355664d6" ], "related_substance": { "uuid": "f65575de-e49d-4959-8851-3a9644d9d28c", "refuuid": "86548993-496b-43a3-9d90-282c7d5d5d70", "name": "ODAPIPAM C-11", "unii": "0T1MK5448L", "linking_id": "0T1MK5448L", "ref_pname": "ODAPIPAM C-11" } }, { "uuid": "881f8600-2dac-4cc0-b61c-51692fa54f51", "amount": { "uuid": "b5514772-b7ce-4527-8537-2fb97282b3f0" }, "type": "RADIOLIGAND->TARGET", "references": [ "a9a57609-b6df-4950-8153-ba8d9b5b1043" ], "related_substance": { "uuid": "c38dd87c-e392-46b4-b131-4faf4c6905d6", "refuuid": "7b36b360-31a2-4f92-aa55-0c73d15e3a03", "name": "SCH-23390 C-11", "unii": "KJ579Y0G68", "linking_id": "KJ579Y0G68", "ref_pname": "SCH-23390 C-11" } }, { "uuid": "9c547d89-e1fe-4799-b9e4-97f167c85b34", "type": "PARTIAL AGONIST->TARGET", "references": [ "c8907c77-e88d-484e-a577-1e3d48075269" ], "related_substance": { "uuid": "e2727087-f0ff-4869-ad09-684ab4763b8c", "refuuid": "5cc4ee2d-a598-4c5f-92bf-68f1fabb2bfa", "name": "CY-208243", "unii": "8GJ4UR780B", "linking_id": "8GJ4UR780B", "ref_pname": "CY-208243" } }, { "uuid": "0abf53a2-0336-4363-a3e4-46fd41429895", "type": "INHIBITOR->TARGET", "references": [ "5ac32da5-262c-4b54-95c3-d89c79affbc5" ], "related_substance": { "uuid": "9c8d5f5e-c539-4aa1-822c-8eb9744e5fa7", "refuuid": "7c7a4205-4044-d4e3-0a04-cadba4714f8b", "name": "NNC-112", "unii": "KH84I8R060", "linking_id": "KH84I8R060", "ref_pname": "NNC-112" } }, { "uuid": "257c491e-d390-404a-a987-146dbbbce9cd", "type": "RADIOLIGAND->TARGET", "references": [ "d6c67b1d-3a82-4f10-9c22-38928529262c" ], "related_substance": { "uuid": "b6f39ce6-8f52-43b8-9a0b-02f5ae415f9a", "refuuid": "257f16a6-4941-4021-bf99-493e8c0360ac", "name": "NNC-112 C-11", "unii": "C2T43FLG0U", "linking_id": "C2T43FLG0U", "ref_pname": "NNC-112 C-11" } }, { "uuid": "16464984-1e5e-4002-9837-1cec86bc49dd", "amount": { "uuid": "a300fe81-a1aa-406d-81a2-29c748a42256" }, "type": "AGONIST->TARGET", "references": [ "393f4331-d42a-4ce1-b438-ea4372752ef5" ], "related_substance": { "uuid": "7787de6b-f42f-4254-89fc-f56b44c0c1e7", "refuuid": "f51c196c-6cf2-4e95-a3ea-435b44b0bd57", "name": "6-FLUORO-DMT", "unii": "J4CZH8D9EN", "linking_id": "J4CZH8D9EN", "ref_pname": "6-FLUORO-DMT" } }, { "uuid": "b8f5c313-d08c-4c7b-a48e-30b4cdd2b3db", "amount": { "uuid": "b535c08c-d926-44b0-b2d2-d7df594cde73" }, "type": "AGONIST->TARGET", "references": [ "ef218167-84ec-438c-99a5-e57303101e3e" ], "related_substance": { "uuid": "0e6c713f-5519-42ec-8b07-fbab53f8be9a", "refuuid": "b714e0ee-d080-4552-924e-a8a46a576f43", "name": "DINOXYLINE", "unii": "9T7B8CV47A", "linking_id": "9T7B8CV47A", "ref_pname": "DINOXYLINE" } }, { "uuid": "44814749-f341-4749-b29a-7f76a57b7bca", "amount": { "uuid": "1bf6b4df-2470-49eb-820e-4b286e19450e", "average": 99.8, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "93b02996-0b28-44e0-9709-0981e731b20c" ], "related_substance": { "uuid": "28285362-e047-4095-ad7e-6e088d4e2af3", "refuuid": "10e9978a-e5a9-4c28-96db-a34a4f76fc53", "name": "Norquetiapine", "unii": "V3H1ZVV9S6", "linking_id": "V3H1ZVV9S6", "ref_pname": "Norquetiapine", "substance_class": "reference" } }, { "uuid": "d12fccc2-d146-404c-a7dc-7085b159862c", "amount": { "uuid": "1d41c8bc-b12b-4791-8164-15af96729c43" }, "type": "INHIBITOR->TARGET", "references": [ "c5e25f8d-64f0-47f7-b348-b796c3750e8b" ], "related_substance": { "uuid": "77bde6d5-a2a1-497e-aec3-528266cab064", "refuuid": "8f208856-b490-4e5e-9b0b-8ccb77e5a475", "name": "ITI-333", "unii": "KHR1GLK9D0", "linking_id": "KHR1GLK9D0", "ref_pname": "ITI-333" } }, { "uuid": "41f19018-fb4e-441e-84fc-74167792dd1e", "type": "AGONIST->TARGET", "references": [ "651db5b5-3ce8-4b94-911d-2f162d4660c8" ], "related_substance": { "uuid": "6911958e-f229-4d20-ab4d-c52c535444ba", "refuuid": "75068be7-e34e-42f2-9a55-f816b5884476", "name": "SKF-81297 HYDROBROMIDE, (R)-", "unii": "J494DH8JRC", "linking_id": "J494DH8JRC", "ref_pname": "SKF-81297 HYDROBROMIDE, (R)-" } }, { "uuid": "cd6fcb2a-9f3d-455d-9719-3e63b460aaa0", "type": "PARENT->INNOVATOR", "references": [ "f1d71db4-5608-4465-9a04-ffcfba5c9195" ], "related_substance": { "uuid": "04891d63-35b6-4b20-956c-55d6e9901afb", "refuuid": "8cf3c091-b65d-497f-831f-44d3b0a0a6c3", "name": "DIHYDREXIDINE, (-)-", "unii": "U4MPC92UC2", "linking_id": "U4MPC92UC2", "ref_pname": "DIHYDREXIDINE, (-)-" } }, { "uuid": "ec94a368-12b8-4435-879e-93c08f57081a", "amount": { "uuid": "6e511109-1a41-41ab-b3e3-dd648e6608d1" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "4cf8c5e5-7209-43a0-8520-8386d73a0d87", "refuuid": "9e0859c7-5014-4c51-a734-ffd7fd412a05", "name": "CORYDALMINE, (-)-", "unii": "DV8DX4568D", "linking_id": "DV8DX4568D", "ref_pname": "CORYDALMINE, (-)-" } }, { "uuid": "f3b59ce9-0e96-44fe-be94-f984231cf39e", "type": "AGONIST->TARGET", "references": [ "dfbf8e0f-6b8b-45bd-a58b-97d5ee890526" ], "related_substance": { "uuid": "a0283648-b304-46bd-a148-7e3fc47bb0c0", "refuuid": "4abeb259-d277-4e89-9272-9b6875087936", "name": "DINAPSOLINE", "unii": "GZ9XC6C5P9", "linking_id": "GZ9XC6C5P9", "ref_pname": "DINAPSOLINE" } }, { "uuid": "84f64873-f4bb-4e85-a23d-39862cb5f0f3", "amount": { "uuid": "9dc234e6-7d01-461a-a023-fc0f5c0f5038" }, "type": "LIGAND->TARGET", "references": [ "7bb992fd-04e2-4e04-85db-64ec966e765a" ], "related_substance": { "uuid": "c0984cdb-6f41-4e52-a664-d6ac10abae4d", "refuuid": "8cfbe220-5321-436d-8c54-cc19d68ca0c6", "name": "CYANODOTHIEPIN", "unii": "KK5VES2GLD", "linking_id": "KK5VES2GLD", "ref_pname": "CYANODOTHIEPIN" } }, { "uuid": "ecdcb38a-56bf-4824-98cd-d8be794e0876", "amount": { "uuid": "13909e41-599c-4bd8-87e5-a44cd979bbff" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "f9dbe8a3-daa3-4a5d-bc4a-e5dc271942b5", "refuuid": "750e1a38-cca9-4fae-ab08-a00f891c3eb7", "name": "BERUPIPAM", "unii": "420895MAOC", "linking_id": "420895MAOC", "ref_pname": "BERUPIPAM", "substance_class": "reference" } }, { "uuid": "d2cf0ba2-19ad-4a67-a283-8cfbb2f5372f", "amount": { "uuid": "5152b4ed-cb37-403a-aae7-200fdf5f1805", "average": 180, "high": 213, "low": 147, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "LIGAND->OFF TARGET", "interaction_type": "BINDING", "references": [ "d0961bc7-58a9-4300-8a6e-186f35622b5f" ], "related_substance": { "uuid": "f63455bb-da9c-41a9-8a13-f314bda129c3", "refuuid": "47838978-2214-4228-a38b-9ed5b1b283a3", "name": "LYSERGIDE", "unii": "8NA5SWF92O", "linking_id": "8NA5SWF92O", "ref_pname": "LYSERGIDE", "substance_class": "reference" } }, { "uuid": "afc919bc-d35a-41d1-8c72-520ef716dfe4", "amount": { "uuid": "846d2319-b862-4668-b275-864ed4e9179b" }, "type": "INHIBITOR->TARGET", "references": [ "0355e5aa-e784-46a2-90b8-7010d96af51c" ], "related_substance": { "uuid": "eba31dbe-462b-45f3-976a-2f4321057372", "refuuid": "7406b90a-e42f-49b7-8aaa-be5043ade6de", "name": "ZICRONAPINE", "unii": "QZV11V7G6A", "linking_id": "QZV11V7G6A", "ref_pname": "ZICRONAPINE", "substance_class": "reference" } }, { "uuid": "21f0dcf9-e017-49a0-a220-95f2b9f837ab", "amount": { "uuid": "86bc1f8d-ff14-40c4-81cd-85180c6eb3d7" }, "type": "POSITIVE ALLOSTERIC MODULATOR (PAM)->TARGET", "related_substance": { "uuid": "0a97006f-2fa3-4af1-8cde-d0bef30250bd", "refuuid": "bef2252a-d55d-4120-a6ce-b7c0b086891d", "name": "Glovadalen", "unii": "H8T5VKH4CZ", "linking_id": "H8T5VKH4CZ", "ref_pname": "Glovadalen", "substance_class": "reference" } }, { "uuid": "38c852f7-1d07-4924-933c-a74629917393", "amount": { "uuid": "e0a587d4-0ec2-4617-8585-394a74c2d6ec" }, "type": "AGONIST->TARGET", "related_substance": { "uuid": "3508b9d3-9fdd-4fc4-a469-d529422a415f", "refuuid": "1784bae6-1af0-4c8b-918f-60cfc0a56206", "name": "ZELANDOPAM", "unii": "IR6XYD8SAX", "linking_id": "IR6XYD8SAX", "ref_pname": "ZELANDOPAM", "substance_class": "reference" } }, { "uuid": "a856f74a-19e4-4195-9b8d-dde2ab5e42bf", "amount": { "uuid": "2464f3bc-6648-4e50-b11d-0a994222b4ff" }, "type": "INHIBITOR->TARGET", "references": [ "93c3175b-ccd5-474b-9ded-8bec0d378f0d" ], "related_substance": { "uuid": "16819aa1-1b4c-4006-928b-7ad30f3740a2", "refuuid": "b60c7573-3da3-435f-b90d-57f04b4c9a01", "name": "ZUCLOPENTHIXOL", "unii": "47ISU063SG", "linking_id": "47ISU063SG", "ref_pname": "ZUCLOPENTHIXOL", "substance_class": "reference" } }, { "uuid": "ed56cd1f-d270-459a-8098-c8e445fb2cea", "amount": { "uuid": "ca4fef62-cec2-45f8-aee3-0a1e7c98e598", "average": 0.9, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "AGONIST->TARGET", "references": [ "e755d664-c028-4570-a35c-8aacfff90531" ], "related_substance": { "uuid": "5ed550b0-925d-454d-85f7-48d36ca88314", "refuuid": "11cfc6b9-4651-4a5c-98b9-284d8fbe2b50", "name": "DOPAMINE", "unii": "VTD58H1Z2X", "linking_id": "VTD58H1Z2X", "ref_pname": "DOPAMINE", "substance_class": "reference" } }, { "uuid": "ca006e0a-1e79-4e9a-bed3-4167fcb5827e", "amount": { "uuid": "e0ddeeb0-0ec3-4ff7-a4d3-5da991fc6359", "average": 0.2, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "376f49f1-14f6-42ce-b731-e3cc86d57707" ], "related_substance": { "uuid": "366427f6-3d7e-4491-8387-9b8462f4f0d1", "refuuid": "13369292-c650-4ac4-be6a-dadb9d87a173", "name": "SCH-23390", "unii": "UGT5535REQ", "linking_id": "UGT5535REQ", "ref_pname": "SCH-23390", "substance_class": "reference" } }, { "uuid": "866f75ad-b5b3-4f0c-8a23-a62eea466b53", "amount": { "uuid": "93e2e994-7d8f-4604-997a-ca0dd63bf3be", "average": 80, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "WEAK INHIBITOR->TARGET", "references": [ "b5ad9580-1355-4543-8a89-aa98e76544d3" ], "related_substance": { "uuid": "a1d6430c-504a-4ec6-beee-15cd9ffb0c90", "refuuid": "cb034a38-8a43-4112-9760-cae598710d66", "name": "HALOPERIDOL", "unii": "J6292F8L3D", "linking_id": "J6292F8L3D", "ref_pname": "HALOPERIDOL", "substance_class": "reference" } } ], "names": [ { "uuid": "6e30cf99-3bff-4c30-848c-2504eca115fc", "name": "D(1A) DOPAMINE RECEPTOR", "stdName": "D(1A) DOPAMINE RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "38642b90-c9a0-4bd2-9ee3-033947720c9b", "49d13775-f51c-4667-9964-47ca190e2048" ], "display_name": true }, { "uuid": "e5c77b9f-d826-4c67-a39d-96cb78fc34a6", "name": "D1", "stdName": "D1", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1b2a8d29-1a45-4b61-93c8-1bff00944506" ], "display_name": false }, { "uuid": "5886cffc-7760-4883-be20-48aa85373062", "name": "D1 DOPAMINE RECEPTOR", "stdName": "D1 DOPAMINE RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d864c48c-18e0-4f45-aea9-2dd2eefdf2fa" ], "display_name": false }, { "uuid": "d9ccf945-eb90-433e-9424-82d3338d2559", "name": "DOPAMINE D1 RECEPTOR", "stdName": "DOPAMINE D1 RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "38642b90-c9a0-4bd2-9ee3-033947720c9b", "1b2a8d29-1a45-4b61-93c8-1bff00944506" ], "display_name": false } ], "protein": { "uuid": "d70ba65b-c8a5-4b4c-8936-d012948dd8ee", "glycosylation": { "uuid": "d8357418-19ae-4177-bd24-f0c175c18d4a", "glycosylation_type": "HUMAN", "n_glycosylation_sites": [ { "residue_index": 5, "subunit_index": 1 } ] }, "subunits": [ { "uuid": "6a85f785-aa55-4abc-a768-e38e723802d8", "sequence": "MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT", "subunit_index": 1 } ], "references": [ "49d13775-f51c-4667-9964-47ca190e2048", "5a0c19b4-8863-49b6-9865-b7d3b624b6aa" ], "disulfide_links": [ { "sites": [ { "residue_index": 96, "subunit_index": 1 }, { "residue_index": 186, "subunit_index": 1 } ] } ], "protein_sub_type": "", "sequence_type": "COMPLETE" }, "properties": [ { "uuid": "f9787b68-632d-4c9a-9a00-fd94887f4cae", "name": "MOL_WEIGHT", "type": "amount", "value": { "uuid": "4addb30f-79ca-4ae3-8fe3-a39c6bfd7f99", "units": "DA" }, "defining": false, "property_type": "CHEMICAL" }, { "uuid": "54511003-4dd1-43cc-8161-811c39e9fdb4", "name": "Molecular Formula", "value": { "uuid": "6d9f9bde-cc3a-4f76-9ad4-7dc3b4ff66af", "type": "ESTIMATED", "non_numeric_value": "C2234H3483N578O627S25" }, "defining": false, "property_type": "CHEMICAL" } ], "modifications": { "uuid": "1374fb24-9d63-44e0-b45a-fb1ba0d31dc2" } } ] }